OpenLB
Open Library of Bioscience
Advanced Search
Microbes and infection
06, 2022;24 (4): 104950.

Therapeutic approaches for combating Pseudomonas aeruginosa infections.

Vijeta Jangra, Namita Sharma, Anil Kumar Chhillar
Author Information
  1. Vijeta Jangra: Centre for Biotechnology, MDU, Rohtak, 124001, India.
  2. Namita Sharma: Centre for Biotechnology, MDU, Rohtak, 124001, India.
  3. Anil Kumar Chhillar: Centre for Biotechnology, MDU, Rohtak, 124001, India. Electronic address: anil.chhillar@gmail.com.
PMID: 35139390 DOI: 10.1016/j.micinf.2022.104950

Abstract

Pseudomonas aeruginosa is an opportunistic pathogen responsible for acute hospital-acquired infections. This review described various therapeutic approaches to treat infections caused by P. aeruginosa, including conventional therapy, novel antibiotic treatments and treatments other than antibiotics. Most of the developments are still in research that will provide novel treatment options in future.

Keywords

Novel antibiotics Pseudomonas aeruginosa Resistance mechanisms Therapeutic treatments

MeSH Term

Anti-Bacterial Agents
Humans
Pseudomonas Infections
Pseudomonas aeruginosa

Chemicals

Anti-Bacterial Agents
Journal Article Review Research Support, Non-U.S. Gov't
Article has an altmetric score of 2

Word Cloud

Created with Highcharts 10.0.0PseudomonasaeruginosainfectionstreatmentsapproachesnovelantibioticsTherapeuticopportunisticpathogenresponsibleacutehospital-acquiredreviewdescribedvarioustherapeutictreatcausedP aeruginosaincludingconventionaltherapyantibioticdevelopmentsstillresearchwillprovidetreatmentoptionsfuturecombatingNovelResistancemechanisms

Similar Articles

Cited By (19)